MSTX Key Stats
PR Newswire08/11 08:00
PR Newswire08/07 08:00
Street Insider08/06 08:54
Street Insider06/24 10:30
MSTX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Mast Therapeutics is up 43.87% over the last year vs S&P 500 Total Return up 24.70%, Onconova Therapeutics down 79.62%, and 22nd Century Group up 163.5%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for MSTX
Portfolio Strategies Featuring MSTX
Did Mast Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.masttherapeutics.com
- IR Website: http://www.masttherapeutics.com/investors/
- HQ Country: United States
- HQ State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: September 30, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: June 30, 2013
- Last Fiscal Year End: December 31, 2013
- NAICS: Pharmaceutical Preparation Manufacturing
- NAICS Code: 325412
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
Mast Therapeutics Inc is a biopharmaceutical company developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its pipeline includes MST-188 development programs in adjunctive thrombolytic therapy.
MSTX Excel Add-In Codes
- Name: =YCI("MSTX","name")
- Description: =YCI("MSTX","description")
- Sector: =YCI("MSTX","sector")
- Industry: =YCI("MSTX","industry")
- Est. Current Fiscal Year End: =YCI("MSTX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.